Letrozole and Lapatinib Followed by Everolimus in Women With Advanced Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms|Endocrine Breast Diseases|Neoplasm Metastasis
Interventions: DRUG: letrozole|DRUG: lapatinib|DRUG: everolimus
Sponsor: University of Maryland, Baltimore
Collaborators: Novartis Pharmaceuticals|GlaxoSmithKline